chr4-9782153-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000798.5(DRD5):c.124G>A(p.Val42Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000021 in 1,427,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000798.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypouricemia, renal, 2Inheritance: AD, AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary renal hypouricemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRD5 | ENST00000304374.4 | c.124G>A | p.Val42Ile | missense_variant | Exon 1 of 1 | 6 | NM_000798.5 | ENSP00000306129.2 | ||
SLC2A9 | ENST00000503803.5 | n.386-2088C>T | intron_variant | Intron 3 of 3 | 3 | |||||
SLC2A9 | ENST00000508585.5 | n.182-10784C>T | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.00000470 AC: 1AN: 212760 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000210 AC: 3AN: 1427918Hom.: 0 Cov.: 30 AF XY: 0.00000283 AC XY: 2AN XY: 706486 show subpopulations
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.124G>A (p.V42I) alteration is located in exon 1 (coding exon 1) of the DRD5 gene. This alteration results from a G to A substitution at nucleotide position 124, causing the valine (V) at amino acid position 42 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at